EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

A rotavirus VP4 or VP7 monoreassortant panel identifies genotypes that are less susceptible to neutralization by systemic antibodies induced by vaccination or natural infection

Tomohiro Kotaki iD, Yuta Kanai, Kristen M Ogden iD, Megumi Onishi, Kattareeya Kumthip iD, Pattara Khamrin, Patcharaporn Boonyos iD, Pornkamol Phoosangwalthong, Phakapun Singchai, Tipsuda Luechakham, Shohei Minami iD, Zelin Chen und 6 weitere

mBio · 2025

DOI: 10.1128/mbio.00897-25 ↗

Kurz gefasst

Fachartikel in der Zeitschrift mBio, 2025. Verfasst von Tomohiro Kotaki und 17 weiteren Autor:innen. Beteiligte Einrichtung: Department of Virology, Research Institute for Microbial Diseases, The University of Osaka, Osaka, Japan. Hauptthemen laut MEDLINE: Antibodies, Neutralizing, Capsid Proteins, Rotavirus, Genotype. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 72 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: BIKEN Foundation, NIDDK NIH HHS, Japan Agency for Medical Research and Development.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Rotavirus infections remain a significant cause of morbidity and mortality in infants. The viral surface proteins VP4 and VP7 are each classified into multiple genotypes (P[1]–P[58] for VP4 and G1–G42 for VP7), which differ in their susceptibility to neutralizing antibodies; however, detailed analyses of these differences remain limited. This study investigates the susceptibility of diverse VP4 and VP7 genotypes to neutralizing antibodies induced by vaccination or natural infection. A reverse genetics system based on the human rotavirus Odelia strain (G4P[8]) was used to create monoreassortant viruses by replacing the VP4 or VP7 genes with those from clinical isolates (obtained in Thailand) or prototype strains. We generated 11 VP4 and 19 VP7 reassortants, covering 7 and 17 genotypes, respectively. Neutralization tests using the monoreassortant viruses, immune sera, and MA104 cells indicate that the VP7 genotype, rather than the VP4 genotype, primarily influences susceptibility to neutralization. Furthermore, genotypes G2, bat-like G3, G11, G12, G25, and G33 were significantly less susceptible to sera from naturally infected Thai individuals, highlighting the importance of monitoring these genotypes. To identify the protein region responsible for susceptibility to neutralization, we generated chimeric viruses by exchanging the domains of high- and low-susceptibility VP7 genotypes and found that Domain I appears to play a substantial role in determining susceptibility. Thus, we identified multiple rotavirus genotypes with reduced susceptibility to neutralization, as well as the region primarily responsible for this reduction. These findings may help to predict possible future rotavirus outbreaks in humans and facilitate the development of effective rotavirus vaccines. IMPORTANCE Rotavirus, the leading cause of severe acute gastroenteritis in infants, is responsible for approximately 128,500 infant deaths globally each year. The virus’s surface proteins are highly diverse, comprising approximately 100 genotypes. This diversity affects susceptibility to neutralizing antibodies and the efficacy of vaccines. Here, we found that certain genotypes are highly resistant to serum neutralizing antibodies induced by vaccination and natural infections. Furthermore, we identified a specific region in the viral outer capsid protein that plays a significant role in determining susceptibility to neutralization. These findings may be important for predicting outbreak-causing strains and for developing more effective vaccines, ultimately contributing to the prevention of future outbreaks and improving global infant health.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antibodies, NeutralizingCapsid ProteinsRotavirusGenotypeAntigens, ViralAntibodies, ViralRotavirus InfectionsRotavirus VaccinesHumansNeutralization TestsReassortant VirusesThailandVaccinationReverse Genetics

Stichwörter der Autor:innen

VP4VP7genotypeneutralization susceptibilityreverse geneticsrotavirusvaccine

Substanzen

Antibodies, NeutralizingCapsid ProteinsAntigens, ViralAntibodies, ViralVP4 protein, RotavirusVP7 protein, RotavirusRotavirus Vaccines

Autor:innen und Institutionen

  • Department of Virology, Research Institute for Microbial Diseases, The University of Osaka, Osaka, Japan.
  • Department of Pediatrics, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
  • Department of Microbiology, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand.
  • Center of Excellence in Emerging and Re-emerging Diarrheal Viruses, Chiang Mai University, Chiang Mai, Thailand.
  • Thailand-Japan Research Collaboration Center on Emerging and Re-emerging Infections, Nonthaburi, Thailand.
  • Department of Medical Sciences, Ministry of Public Health, Nonthaburi, Thailand.

ORCID-Profile: Tomohiro Kotaki, Kristen M Ogden, Kattareeya Kumthip, Patcharaporn Boonyos, Shohei Minami, Niwat Maneekarn, Takeshi Kobayashi

Förderung

  • BIKEN Foundation
  • NIDDK NIH HHS
  • Japan Agency for Medical Research and Development
  • Moonshot Research and Development Program
  • Japan Society for the Promotion of Science

Zitieren

APA

Kotaki, T., Kanai, Y., Ogden, K. M., Onishi, M., Kumthip, K., Khamrin, P., Boonyos, P., Phoosangwalthong, P., Singchai, P., Luechakham, T., Minami, S., Chen, Z., Hirai, K., Tacharoenmuang, R., Mizushima, H., Ushijima, H., Maneekarn, N., & Kobayashi, T. (2025). A rotavirus VP4 or VP7 monoreassortant panel identifies genotypes that are less susceptible to neutralization by systemic antibodies induced by vaccination or natural infection. mBio. https://doi.org/10.1128/mbio.00897-25

Vancouver

Kotaki T, Kanai Y, Ogden KM, Onishi M, Kumthip K, Khamrin P, et al. A rotavirus VP4 or VP7 monoreassortant panel identifies genotypes that are less susceptible to neutralization by systemic antibodies induced by vaccination or natural infection. mBio. 2025. doi:10.1128/mbio.00897-25

BibTeX
@article{Kotaki2025,
  author = {Kotaki, Tomohiro and Kanai, Yuta and Ogden, Kristen M and Onishi, Megumi and Kumthip, Kattareeya and Khamrin, Pattara and Boonyos, Patcharaporn and Phoosangwalthong, Pornkamol and Singchai, Phakapun and Luechakham, Tipsuda and Minami, Shohei and Chen, Zelin and Hirai, Katsuhisa and Tacharoenmuang, Ratana and Mizushima, Hiroto and Ushijima, Hiroshi and Maneekarn, Niwat and Kobayashi, Takeshi},
  title = {A rotavirus VP4 or VP7 monoreassortant panel identifies genotypes that are less susceptible to neutralization by systemic antibodies induced by vaccination or natural infection},
  journal = {mBio},
  year = {2025},
  doi = {10.1128/mbio.00897-25}
}
Kostenlos starten →